PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
elf2a
|
ENSDARG00000019459 | E74-like factor 2a (ets domain transcription factor) |
elf2b
|
ENSDARG00000079626 | E74-like factor 2b (ets domain transcription factor) |
elf2b
|
ENSDARG00000117064 | E74-like factor 2b (ets domain transcription factor) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
elf2b | dr11_v1_chr1_-_13989643_13989643 | 0.82 | 7.5e-24 | Click! |
elf2a | dr11_v1_chr14_-_46070802_46070802 | 0.80 | 2.1e-22 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_-_6982499 | 22.52 |
ENSDART00000101525
|
si:dkey-266m15.6
|
si:dkey-266m15.6 |
chr1_-_45177373 | 22.46 |
ENSDART00000143142
ENSDART00000034549 |
zgc:111983
|
zgc:111983 |
chr4_-_76383223 | 19.55 |
ENSDART00000161866
ENSDART00000168456 ENSDART00000174287 ENSDART00000174048 |
zgc:123107
|
zgc:123107 |
chr15_+_42573909 | 19.51 |
ENSDART00000181801
|
CLDN8 (1 of many)
|
zgc:110333 |
chr16_-_45001842 | 18.53 |
ENSDART00000037797
|
sult2st3
|
sulfotransferase family 2, cytosolic sulfotransferase 3 |
chr22_+_5478353 | 17.75 |
ENSDART00000160596
|
tppp
|
tubulin polymerization promoting protein |
chr1_-_26026956 | 17.18 |
ENSDART00000102346
|
si:ch211-145b13.6
|
si:ch211-145b13.6 |
chr14_-_33277743 | 15.85 |
ENSDART00000048130
|
stard14
|
START domain containing 14 |
chr24_-_26328721 | 13.96 |
ENSDART00000125468
|
apodb
|
apolipoprotein Db |
chr15_-_2652640 | 13.95 |
ENSDART00000146094
|
cldnf
|
claudin f |
chr11_-_3865472 | 13.64 |
ENSDART00000161426
|
gata2a
|
GATA binding protein 2a |
chr2_+_49457626 | 13.55 |
ENSDART00000129967
|
sh3gl1a
|
SH3-domain GRB2-like 1a |
chr19_+_43359075 | 13.00 |
ENSDART00000148287
ENSDART00000149856 ENSDART00000188236 ENSDART00000136695 ENSDART00000193859 |
yrk
|
Yes-related kinase |
chr3_+_32492467 | 12.95 |
ENSDART00000151329
|
trpm4a
|
transient receptor potential cation channel, subfamily M, member 4a |
chr1_-_26027327 | 12.93 |
ENSDART00000171292
ENSDART00000170878 |
si:ch211-145b13.6
|
si:ch211-145b13.6 |
chr14_+_20911310 | 12.62 |
ENSDART00000160318
|
lygl2
|
lysozyme g-like 2 |
chr14_-_33278084 | 12.61 |
ENSDART00000132850
|
stard14
|
START domain containing 14 |
chr3_+_32416948 | 12.42 |
ENSDART00000157324
ENSDART00000154267 ENSDART00000186094 ENSDART00000155860 ENSDART00000156986 |
prrg2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
chr12_+_22576404 | 12.22 |
ENSDART00000172053
|
capgb
|
capping protein (actin filament), gelsolin-like b |
chr16_+_17715243 | 12.21 |
ENSDART00000149437
ENSDART00000149596 |
si:dkey-87o1.2
|
si:dkey-87o1.2 |
chr15_+_36445350 | 11.73 |
ENSDART00000154552
|
si:dkey-262k9.2
|
si:dkey-262k9.2 |
chr1_-_37383539 | 11.48 |
ENSDART00000127579
|
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr4_+_18843015 | 11.43 |
ENSDART00000152086
ENSDART00000066977 ENSDART00000132567 |
bik
|
BCL2 interacting killer |
chr20_+_46040666 | 11.37 |
ENSDART00000060744
|
si:dkey-7c18.24
|
si:dkey-7c18.24 |
chr2_+_20967673 | 11.34 |
ENSDART00000057174
|
arpc5a
|
actin related protein 2/3 complex, subunit 5A |
chr21_+_30794351 | 11.25 |
ENSDART00000139486
|
zgc:158225
|
zgc:158225 |
chr15_+_3808996 | 11.24 |
ENSDART00000110227
|
RNF14 (1 of many)
|
ring finger protein 14 |
chr5_+_27404946 | 11.20 |
ENSDART00000121886
ENSDART00000005025 |
hdr
|
hematopoietic death receptor |
chr14_-_32876280 | 11.14 |
ENSDART00000173168
|
si:rp71-46j2.7
|
si:rp71-46j2.7 |
chr3_-_32337653 | 11.07 |
ENSDART00000156918
ENSDART00000156551 |
si:dkey-16p21.8
|
si:dkey-16p21.8 |
chr17_-_26935339 | 11.05 |
ENSDART00000139946
|
nipal3
|
NIPA-like domain containing 3 |
chr3_-_27647845 | 11.02 |
ENSDART00000151625
|
si:ch211-157c3.4
|
si:ch211-157c3.4 |
chr13_-_36391496 | 10.98 |
ENSDART00000100217
ENSDART00000140243 |
actn1
|
actinin, alpha 1 |
chr17_-_8886735 | 10.67 |
ENSDART00000121997
|
nkl.3
|
NK-lysin tandem duplicate 3 |
chr3_-_27646070 | 10.61 |
ENSDART00000122031
ENSDART00000151027 |
si:ch211-157c3.4
|
si:ch211-157c3.4 |
chr22_+_21549419 | 10.60 |
ENSDART00000139411
|
plpp2b
|
phospholipid phosphatase 2b |
chr11_-_11890001 | 10.60 |
ENSDART00000081544
|
wipf2a
|
WAS/WASL interacting protein family, member 2a |
chr3_+_53240562 | 10.56 |
ENSDART00000031234
|
stxbp2
|
syntaxin binding protein 2 |
chr3_-_39488482 | 10.48 |
ENSDART00000135192
|
zgc:100868
|
zgc:100868 |
chr16_-_31976269 | 10.25 |
ENSDART00000139664
|
styk1
|
serine/threonine/tyrosine kinase 1 |
chr8_-_21052371 | 10.22 |
ENSDART00000136561
|
si:dkeyp-82a1.6
|
si:dkeyp-82a1.6 |
chr16_+_11818126 | 10.22 |
ENSDART00000145727
|
cxcr3.2
|
chemokine (C-X-C motif) receptor 3, tandem duplicate 2 |
chr5_+_56026031 | 10.14 |
ENSDART00000050970
|
fzd9a
|
frizzled class receptor 9a |
chr6_-_39313027 | 10.09 |
ENSDART00000012644
|
krt4
|
keratin 4 |
chr1_+_56180416 | 10.00 |
ENSDART00000089358
|
crb3b
|
crumbs homolog 3b |
chr3_+_5331428 | 9.99 |
ENSDART00000156561
|
si:ch73-106l15.4
|
si:ch73-106l15.4 |
chr5_-_12587053 | 9.88 |
ENSDART00000162780
|
vsig10
|
V-set and immunoglobulin domain containing 10 |
chr5_-_37116265 | 9.83 |
ENSDART00000057613
|
il13ra2
|
interleukin 13 receptor, alpha 2 |
chr1_-_37383741 | 9.82 |
ENSDART00000193155
ENSDART00000191887 ENSDART00000189077 |
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr6_+_18142623 | 9.79 |
ENSDART00000169431
ENSDART00000158841 |
si:dkey-237i9.8
|
si:dkey-237i9.8 |
chr7_-_25133783 | 9.61 |
ENSDART00000173781
ENSDART00000121943 ENSDART00000077219 |
badb
|
BCL2 associated agonist of cell death b |
chr2_+_49457449 | 9.49 |
ENSDART00000185470
|
sh3gl1a
|
SH3-domain GRB2-like 1a |
chr19_-_11015238 | 9.46 |
ENSDART00000010997
|
tpm3
|
tropomyosin 3 |
chr4_-_18954001 | 9.44 |
ENSDART00000144814
|
si:dkey-31f5.8
|
si:dkey-31f5.8 |
chr22_-_26353916 | 9.41 |
ENSDART00000077958
|
capn2b
|
calpain 2, (m/II) large subunit b |
chr9_-_3400727 | 9.38 |
ENSDART00000183979
ENSDART00000111386 |
dlx2a
|
distal-less homeobox 2a |
chr20_-_5369105 | 9.24 |
ENSDART00000114316
|
sptlc2b
|
serine palmitoyltransferase, long chain base subunit 2b |
chr4_+_22680442 | 9.23 |
ENSDART00000036531
|
gnai1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr24_-_31306724 | 9.17 |
ENSDART00000165399
|
acp5b
|
acid phosphatase 5b, tartrate resistant |
chr12_-_22355430 | 9.07 |
ENSDART00000153296
ENSDART00000056919 ENSDART00000159036 |
nsfb
|
N-ethylmaleimide-sensitive factor b |
chr7_+_71764883 | 9.06 |
ENSDART00000166865
|
myl12.1
|
myosin, light chain 12, genome duplicate 1 |
chr16_+_35918463 | 8.97 |
ENSDART00000160608
|
sh3d21
|
SH3 domain containing 21 |
chr23_+_18779043 | 8.97 |
ENSDART00000158267
|
emp3b
|
epithelial membrane protein 3b |
chr14_-_34059681 | 8.83 |
ENSDART00000003993
|
itk
|
IL2 inducible T cell kinase |
chr11_+_37265692 | 8.83 |
ENSDART00000184691
|
il17rc
|
interleukin 17 receptor C |
chr8_+_3426522 | 8.72 |
ENSDART00000159466
|
CU929199.1
|
|
chr24_-_11076400 | 8.72 |
ENSDART00000003195
|
chmp4c
|
charged multivesicular body protein 4C |
chr22_+_5687615 | 8.61 |
ENSDART00000133241
ENSDART00000019854 ENSDART00000138102 |
dnase1l4.2
|
deoxyribonuclease 1 like 4, tandem duplicate 2 |
chr17_+_34805897 | 8.56 |
ENSDART00000137090
ENSDART00000077626 |
id2a
|
inhibitor of DNA binding 2a |
chr5_-_42272517 | 8.52 |
ENSDART00000137692
ENSDART00000164363 |
si:ch211-207c6.2
|
si:ch211-207c6.2 |
chr20_-_40717900 | 8.44 |
ENSDART00000181663
|
cx43
|
connexin 43 |
chr17_-_8862424 | 8.41 |
ENSDART00000064633
|
nkl.4
|
NK-lysin tandem duplicate 4 |
chr17_-_30666037 | 8.39 |
ENSDART00000156509
|
alkal2b
|
ALK and LTK ligand 2b |
chr2_+_19163965 | 8.37 |
ENSDART00000166073
|
elovl1a
|
ELOVL fatty acid elongase 1a |
chr6_-_49063085 | 8.33 |
ENSDART00000156124
|
si:ch211-105j21.9
|
si:ch211-105j21.9 |
chr14_+_31865099 | 8.28 |
ENSDART00000189124
|
tm9sf5
|
transmembrane 9 superfamily protein member 5 |
chr18_-_35459996 | 8.24 |
ENSDART00000141023
|
itpkcb
|
inositol-trisphosphate 3-kinase Cb |
chr8_+_32406885 | 8.24 |
ENSDART00000167600
|
epgn
|
epithelial mitogen homolog (mouse) |
chr18_-_17485419 | 8.19 |
ENSDART00000018764
|
foxl1
|
forkhead box L1 |
chr3_+_34846201 | 8.19 |
ENSDART00000055263
|
itga3a
|
integrin, alpha 3a |
chr16_+_7242610 | 8.17 |
ENSDART00000081477
|
sri
|
sorcin |
chr6_+_34038963 | 8.09 |
ENSDART00000057732
ENSDART00000192496 |
ap1m3
|
adaptor-related protein complex 1, mu 3 subunit |
chr1_-_50247 | 8.00 |
ENSDART00000168428
|
ildr1a
|
immunoglobulin-like domain containing receptor 1a |
chr6_-_21616659 | 7.92 |
ENSDART00000074256
|
ppp1r12c
|
protein phosphatase 1, regulatory subunit 12C |
chr14_+_31865324 | 7.91 |
ENSDART00000039880
|
tm9sf5
|
transmembrane 9 superfamily protein member 5 |
chr5_+_4366431 | 7.87 |
ENSDART00000168560
ENSDART00000149185 |
sat1a.2
|
spermidine/spermine N1-acetyltransferase 1a, duplicate 2 |
chr21_-_8085635 | 7.85 |
ENSDART00000082790
|
si:dkey-163m14.2
|
si:dkey-163m14.2 |
chr12_-_7234915 | 7.75 |
ENSDART00000048866
|
ipmkb
|
inositol polyphosphate multikinase b |
chr22_-_11833317 | 7.74 |
ENSDART00000125423
ENSDART00000000192 |
ptpn4b
|
protein tyrosine phosphatase, non-receptor type 4b |
chr22_+_35068046 | 7.73 |
ENSDART00000161660
ENSDART00000169573 |
si:ch73-173h19.3
|
si:ch73-173h19.3 |
chr17_+_50261603 | 7.73 |
ENSDART00000154503
ENSDART00000154467 |
syncripl
|
synaptotagmin binding, cytoplasmic RNA interacting protein, like |
chr23_+_36653376 | 7.73 |
ENSDART00000053189
|
gpr182
|
G protein-coupled receptor 182 |
chr23_+_10146542 | 7.67 |
ENSDART00000048073
|
zgc:171775
|
zgc:171775 |
chr12_-_33789006 | 7.66 |
ENSDART00000034550
|
llgl2
|
lethal giant larvae homolog 2 (Drosophila) |
chr19_-_9522548 | 7.64 |
ENSDART00000045245
|
ing4
|
inhibitor of growth family, member 4 |
chr21_+_22738939 | 7.60 |
ENSDART00000151342
ENSDART00000079145 |
arhgap42a
|
Rho GTPase activating protein 42a |
chr25_+_33202294 | 7.56 |
ENSDART00000131098
|
TPM1 (1 of many)
|
zgc:171719 |
chr14_-_22015232 | 7.55 |
ENSDART00000137795
|
ssrp1a
|
structure specific recognition protein 1a |
chr2_+_6243144 | 7.52 |
ENSDART00000058258
|
gng5
|
guanine nucleotide binding protein (G protein), gamma 5 |
chr21_+_22985078 | 7.47 |
ENSDART00000156491
|
lpar6b
|
lysophosphatidic acid receptor 6b |
chr6_-_8489810 | 7.45 |
ENSDART00000124643
|
rasal3
|
RAS protein activator like 3 |
chr25_-_22191983 | 7.40 |
ENSDART00000191181
|
pkp3a
|
plakophilin 3a |
chr1_-_44581937 | 7.38 |
ENSDART00000009858
|
tmx2b
|
thioredoxin-related transmembrane protein 2b |
chr23_-_5818992 | 7.38 |
ENSDART00000148730
|
csrp1a
|
cysteine and glycine-rich protein 1a |
chr3_+_26814030 | 7.33 |
ENSDART00000180128
|
socs1a
|
suppressor of cytokine signaling 1a |
chr17_-_25382367 | 7.30 |
ENSDART00000162306
ENSDART00000165282 |
lck
|
LCK proto-oncogene, Src family tyrosine kinase |
chr16_-_21038015 | 7.29 |
ENSDART00000059239
|
snx10b
|
sorting nexin 10b |
chr5_+_32141790 | 7.26 |
ENSDART00000041504
|
tescb
|
tescalcin b |
chr13_-_25484659 | 7.22 |
ENSDART00000135321
ENSDART00000022799 |
tial1
|
TIA1 cytotoxic granule-associated RNA binding protein-like 1 |
chr21_+_38638979 | 7.17 |
ENSDART00000143373
|
rbmx2
|
RNA binding motif protein, X-linked 2 |
chr6_+_23810529 | 7.14 |
ENSDART00000166921
|
glulb
|
glutamate-ammonia ligase (glutamine synthase) b |
chr24_+_25069609 | 7.14 |
ENSDART00000115165
|
amer2
|
APC membrane recruitment protein 2 |
chr1_-_25486471 | 7.13 |
ENSDART00000134200
ENSDART00000141892 ENSDART00000102501 |
arfip1
|
ADP-ribosylation factor interacting protein 1 (arfaptin 1) |
chr19_-_29853402 | 7.11 |
ENSDART00000024292
ENSDART00000188508 |
txlna
|
taxilin alpha |
chr8_+_36554816 | 7.04 |
ENSDART00000126687
|
sf3a1
|
splicing factor 3a, subunit 1 |
chr16_+_38277339 | 6.99 |
ENSDART00000085143
|
bnipl
|
BCL2 interacting protein like |
chr1_+_54737353 | 6.99 |
ENSDART00000130675
ENSDART00000162075 |
pi4k2a
|
phosphatidylinositol 4-kinase type 2 alpha |
chr25_+_7784582 | 6.94 |
ENSDART00000155016
|
dgkzb
|
diacylglycerol kinase, zeta b |
chr23_-_5719453 | 6.93 |
ENSDART00000033093
|
lad1
|
ladinin |
chr8_+_25359394 | 6.93 |
ENSDART00000111248
|
si:dkey-183p4.10
|
si:dkey-183p4.10 |
chr3_+_36424055 | 6.87 |
ENSDART00000170318
|
si:ch1073-443f11.2
|
si:ch1073-443f11.2 |
chr16_-_25233515 | 6.76 |
ENSDART00000058943
|
zgc:110182
|
zgc:110182 |
chr15_-_28904371 | 6.74 |
ENSDART00000155154
|
eml2
|
echinoderm microtubule associated protein like 2 |
chr5_+_15203421 | 6.69 |
ENSDART00000040826
|
tbx1
|
T-box 1 |
chr23_-_5101847 | 6.69 |
ENSDART00000122240
|
etv7
|
ets variant 7 |
chr21_-_43328056 | 6.68 |
ENSDART00000114955
|
sowahaa
|
sosondowah ankyrin repeat domain family member Aa |
chr11_-_36263886 | 6.67 |
ENSDART00000140397
|
nfya
|
nuclear transcription factor Y, alpha |
chr1_-_45146834 | 6.64 |
ENSDART00000144997
|
si:ch211-239f4.6
|
si:ch211-239f4.6 |
chr10_+_8875195 | 6.63 |
ENSDART00000141045
|
itga2.3
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), tandem duplicate 3 |
chr19_-_27006764 | 6.62 |
ENSDART00000089540
|
sacm1la
|
SAC1 like phosphatidylinositide phosphatase a |
chr14_-_2602445 | 6.61 |
ENSDART00000166910
|
etf1a
|
eukaryotic translation termination factor 1a |
chr9_-_25989989 | 6.59 |
ENSDART00000090052
|
arhgap15
|
Rho GTPase activating protein 15 |
chr5_-_37959874 | 6.57 |
ENSDART00000031719
|
mpzl2b
|
myelin protein zero-like 2b |
chr6_+_49095646 | 6.51 |
ENSDART00000103385
|
slc25a55a
|
solute carrier family 25, member 55a |
chr9_-_42484444 | 6.51 |
ENSDART00000048320
ENSDART00000047653 |
tfpia
|
tissue factor pathway inhibitor a |
chr4_-_16354292 | 6.51 |
ENSDART00000139919
|
lum
|
lumican |
chr13_+_24402406 | 6.48 |
ENSDART00000043002
|
rab1ab
|
RAB1A, member RAS oncogene family b |
chr25_+_753364 | 6.48 |
ENSDART00000183804
|
TWF1 (1 of many)
|
twinfilin actin binding protein 1 |
chr9_-_48077034 | 6.45 |
ENSDART00000099803
|
arpc2
|
actin related protein 2/3 complex, subunit 2 |
chr25_+_34014523 | 6.45 |
ENSDART00000182856
|
anxa2a
|
annexin A2a |
chr1_+_25650917 | 6.40 |
ENSDART00000054235
|
plrg1
|
pleiotropic regulator 1 |
chr20_+_26916639 | 6.40 |
ENSDART00000077787
|
serpinb1l2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 2 |
chr4_-_12323228 | 6.38 |
ENSDART00000081089
|
il17ra1a
|
interleukin 17 receptor A1a |
chr20_-_32045057 | 6.38 |
ENSDART00000152970
ENSDART00000034248 |
rab32a
|
RAB32a, member RAS oncogene family |
chr20_+_37844035 | 6.38 |
ENSDART00000041397
|
flvcr1
|
feline leukemia virus subgroup C cellular receptor 1 |
chr7_+_74141297 | 6.37 |
ENSDART00000164992
|
rbpms
|
RNA binding protein with multiple splicing |
chr16_-_26232411 | 6.37 |
ENSDART00000139355
|
arhgef1b
|
Rho guanine nucleotide exchange factor (GEF) 1b |
chr20_-_26937453 | 6.35 |
ENSDART00000139756
|
ftr97
|
finTRIM family, member 97 |
chr3_+_3598555 | 6.34 |
ENSDART00000191152
|
CR589947.3
|
|
chr14_+_26224541 | 6.34 |
ENSDART00000128971
|
gm2a
|
GM2 ganglioside activator |
chr23_+_43638982 | 6.34 |
ENSDART00000168646
|
slc10a7
|
solute carrier family 10, member 7 |
chr23_+_20669149 | 6.33 |
ENSDART00000138936
|
arhgef3l
|
Rho guanine nucleotide exchange factor (GEF) 3, like |
chr16_+_13427967 | 6.29 |
ENSDART00000038196
|
zgc:101640
|
zgc:101640 |
chr9_+_426392 | 6.28 |
ENSDART00000172515
|
bzw1b
|
basic leucine zipper and W2 domains 1b |
chr1_+_38142715 | 6.27 |
ENSDART00000079928
|
galnt7
|
UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 |
chr16_+_3982590 | 6.20 |
ENSDART00000149295
|
zc3h12a
|
zinc finger CCCH-type containing 12A |
chr24_-_8409641 | 6.17 |
ENSDART00000149662
ENSDART00000149025 |
slc35b3
|
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 |
chr5_-_30984010 | 6.16 |
ENSDART00000182367
|
spns3
|
spinster homolog 3 (Drosophila) |
chr17_-_2039511 | 6.16 |
ENSDART00000160223
|
spint1a
|
serine peptidase inhibitor, Kunitz type 1 a |
chr20_+_41021054 | 6.15 |
ENSDART00000146052
|
man1a1
|
mannosidase, alpha, class 1A, member 1 |
chr10_-_108952 | 6.14 |
ENSDART00000127228
|
ttc3
|
tetratricopeptide repeat domain 3 |
chr21_+_45626136 | 6.14 |
ENSDART00000158742
|
irf1b
|
interferon regulatory factor 1b |
chr16_+_33144306 | 6.13 |
ENSDART00000101953
|
rhbdl2
|
rhomboid, veinlet-like 2 (Drosophila) |
chr11_-_25853212 | 6.13 |
ENSDART00000145655
|
tmem51b
|
transmembrane protein 51b |
chr19_+_10331325 | 6.11 |
ENSDART00000143930
|
tmem238a
|
transmembrane protein 238a |
chr5_+_23024033 | 6.10 |
ENSDART00000171199
|
chmp1b
|
chromatin modifying protein 1B |
chr15_+_7057050 | 6.06 |
ENSDART00000061828
|
foxl2a
|
forkhead box L2a |
chr18_+_44532370 | 6.05 |
ENSDART00000086952
|
st14a
|
suppression of tumorigenicity 14 (colon carcinoma) a |
chr3_+_43825785 | 6.03 |
ENSDART00000157619
|
litaf
|
lipopolysaccharide-induced TNF factor |
chr24_-_6078222 | 6.01 |
ENSDART00000146830
|
apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr21_+_11778823 | 6.00 |
ENSDART00000031786
|
glrx
|
glutaredoxin (thioltransferase) |
chr1_-_18848955 | 5.99 |
ENSDART00000109294
ENSDART00000146410 |
zgc:195282
|
zgc:195282 |
chr17_+_25397070 | 5.97 |
ENSDART00000164254
|
zgc:154055
|
zgc:154055 |
chr8_-_4694458 | 5.97 |
ENSDART00000019828
|
zgc:63587
|
zgc:63587 |
chr18_+_48423973 | 5.96 |
ENSDART00000184233
ENSDART00000147074 |
fli1a
|
Fli-1 proto-oncogene, ETS transcription factor a |
chr9_-_33081781 | 5.95 |
ENSDART00000165748
|
zgc:172053
|
zgc:172053 |
chr4_+_12966640 | 5.95 |
ENSDART00000113357
|
vhll
|
von Hippel-Lindau tumor suppressor like |
chr3_+_36616713 | 5.93 |
ENSDART00000158284
|
pdxdc1
|
pyridoxal-dependent decarboxylase domain containing 1 |
chr17_+_45395846 | 5.91 |
ENSDART00000058793
|
nenf
|
neudesin neurotrophic factor |
chr19_-_325584 | 5.90 |
ENSDART00000134266
|
gpd1c
|
glycerol-3-phosphate dehydrogenase 1c |
chr18_+_27001115 | 5.90 |
ENSDART00000133547
|
pik3c2a
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
chr23_+_26009266 | 5.90 |
ENSDART00000054025
|
si:dkey-78k11.9
|
si:dkey-78k11.9 |
chr25_-_16724913 | 5.90 |
ENSDART00000157075
|
galnt8a.2
|
polypeptide N-acetylgalactosaminyltransferase 8a, tandem duplicate 2 |
chr21_-_15200556 | 5.90 |
ENSDART00000141809
|
sfswap
|
splicing factor SWAP |
chr18_+_18982077 | 5.89 |
ENSDART00000006300
|
hacd3
|
3-hydroxyacyl-CoA dehydratase 3 |
chr24_-_25004553 | 5.88 |
ENSDART00000080997
ENSDART00000136860 |
zdhhc20b
|
zinc finger, DHHC-type containing 20b |
chr1_-_38170997 | 5.87 |
ENSDART00000142811
|
hmgb2a
|
high mobility group box 2a |
chr14_+_52440161 | 5.85 |
ENSDART00000168437
|
b4galt1l
|
DP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, like |
chr3_+_46479705 | 5.84 |
ENSDART00000181564
|
tyk2
|
tyrosine kinase 2 |
chr10_+_5234327 | 5.83 |
ENSDART00000133927
ENSDART00000063120 |
sptlc1
|
serine palmitoyltransferase, long chain base subunit 1 |
chr16_+_26680508 | 5.82 |
ENSDART00000142215
ENSDART00000159064 |
virma
|
vir like m6A methyltransferase associated |
chr5_+_37087583 | 5.81 |
ENSDART00000049900
|
tagln2
|
transgelin 2 |
chr11_+_43740949 | 5.80 |
ENSDART00000189296
|
CU862021.1
|
|
chr13_+_1155536 | 5.79 |
ENSDART00000148356
|
perp
|
PERP, TP53 apoptosis effector |
chr17_-_30635298 | 5.79 |
ENSDART00000155478
|
sh3yl1
|
SH3 and SYLF domain containing 1 |
chr11_-_21404358 | 5.74 |
ENSDART00000129062
|
ikbke
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
chr11_-_13126505 | 5.74 |
ENSDART00000158377
|
elovl1b
|
ELOVL fatty acid elongase 1b |
chr10_+_27096043 | 5.73 |
ENSDART00000064107
ENSDART00000159751 |
cxadr
|
CXADR, Ig-like cell adhesion molecule |
chr15_-_28085480 | 5.72 |
ENSDART00000060304
ENSDART00000192239 |
dhrs13a.3
|
dehydrogenase/reductase (SDR family) member 13a, duplicate 3 |
chr9_-_4075620 | 5.72 |
ENSDART00000046903
|
mylka
|
myosin, light chain kinase a |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0002369 | T cell cytokine production(GO:0002369) |
4.5 | 13.6 | GO:1902893 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
4.2 | 12.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.6 | 3.6 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
3.4 | 10.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
3.3 | 19.5 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
3.1 | 3.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
3.0 | 12.1 | GO:0006598 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
2.8 | 30.9 | GO:0018120 | peptidyl-arginine ADP-ribosylation(GO:0018120) |
2.8 | 11.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.6 | 13.1 | GO:0010719 | photoreceptor cell morphogenesis(GO:0008594) negative regulation of epithelial to mesenchymal transition(GO:0010719) |
2.3 | 9.1 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
2.2 | 6.7 | GO:0003156 | regulation of organ formation(GO:0003156) |
2.0 | 14.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.0 | 8.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
2.0 | 6.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.0 | 5.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.9 | 7.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.8 | 19.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.7 | 5.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
1.7 | 6.8 | GO:0051645 | Golgi localization(GO:0051645) |
1.6 | 4.9 | GO:0061400 | positive regulation of transcription from RNA polymerase II promoter in response to calcium ion(GO:0061400) |
1.6 | 6.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.6 | 6.4 | GO:0097037 | heme export(GO:0097037) |
1.6 | 6.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.6 | 4.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
1.6 | 4.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.5 | 4.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.5 | 5.9 | GO:0006116 | NADH oxidation(GO:0006116) glycerol-3-phosphate catabolic process(GO:0046168) |
1.5 | 4.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.5 | 4.4 | GO:0071236 | cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
1.4 | 5.8 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
1.4 | 8.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.4 | 4.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.4 | 2.8 | GO:0033337 | dorsal fin development(GO:0033337) |
1.4 | 5.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
1.4 | 4.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
1.4 | 4.2 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism(GO:0043903) |
1.4 | 7.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.4 | 8.4 | GO:0070378 | ERK5 cascade(GO:0070375) regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
1.3 | 4.0 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) |
1.3 | 3.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.3 | 2.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
1.2 | 7.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.2 | 41.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
1.2 | 3.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.2 | 3.6 | GO:0031645 | negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
1.2 | 3.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.2 | 19.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 3.4 | GO:1905072 | cardiac jelly development(GO:1905072) |
1.1 | 4.6 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) cortical granule exocytosis(GO:0060471) |
1.1 | 7.9 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
1.1 | 3.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) symmetric cell division(GO:0098725) |
1.1 | 20.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 3.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
1.1 | 5.4 | GO:0051639 | actin filament network formation(GO:0051639) |
1.1 | 4.4 | GO:0034087 | establishment of mitotic sister chromatid cohesion(GO:0034087) establishment of protein localization to chromosome(GO:0070199) establishment of protein localization to chromatin(GO:0071169) transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.1 | 3.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.1 | 9.5 | GO:2000273 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) positive regulation of receptor activity(GO:2000273) |
1.0 | 4.2 | GO:1904355 | positive regulation of telomere maintenance(GO:0032206) regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
1.0 | 4.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.0 | 7.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.0 | 3.0 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
1.0 | 2.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
1.0 | 3.0 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
1.0 | 5.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.0 | 4.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.0 | 4.9 | GO:0033499 | galactose catabolic process(GO:0019388) galactose catabolic process via UDP-galactose(GO:0033499) |
1.0 | 7.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.0 | 3.9 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.9 | 3.7 | GO:0032655 | interleukin-12 production(GO:0032615) regulation of interleukin-12 production(GO:0032655) |
0.9 | 23.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.9 | 5.5 | GO:0010269 | response to selenium ion(GO:0010269) |
0.9 | 6.4 | GO:0060036 | notochord cell vacuolation(GO:0060036) |
0.9 | 2.7 | GO:0009193 | ribonucleoside diphosphate catabolic process(GO:0009191) pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
0.9 | 6.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.9 | 9.6 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.9 | 22.6 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.9 | 3.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.9 | 5.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.9 | 2.6 | GO:2000637 | negative regulation of hippo signaling(GO:0035331) positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.9 | 4.3 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.9 | 15.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.8 | 16.9 | GO:0007032 | endosome organization(GO:0007032) |
0.8 | 3.4 | GO:2000058 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.8 | 9.2 | GO:0045453 | bone resorption(GO:0045453) |
0.8 | 4.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.8 | 4.0 | GO:0003173 | ventriculo bulbo valve development(GO:0003173) |
0.8 | 3.2 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) positive regulation of immunoglobulin production(GO:0002639) |
0.8 | 6.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 4.0 | GO:0006660 | phosphatidylserine catabolic process(GO:0006660) monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.8 | 1.6 | GO:0034205 | beta-amyloid formation(GO:0034205) amyloid precursor protein catabolic process(GO:0042987) |
0.8 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 4.7 | GO:0032447 | protein urmylation(GO:0032447) |
0.8 | 15.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.8 | 3.8 | GO:1900145 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) |
0.7 | 30.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.7 | 3.6 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) cellular response to virus(GO:0098586) |
0.7 | 5.8 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.7 | 3.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 16.4 | GO:1901654 | response to ketone(GO:1901654) |
0.7 | 2.8 | GO:0003190 | heart valve formation(GO:0003188) atrioventricular valve formation(GO:0003190) |
0.7 | 2.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
0.7 | 4.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 3.4 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.7 | 4.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 4.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 6.5 | GO:0015810 | acidic amino acid transport(GO:0015800) aspartate transport(GO:0015810) L-glutamate transport(GO:0015813) malate-aspartate shuttle(GO:0043490) |
0.6 | 15.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 2.6 | GO:0071867 | response to monoamine(GO:0071867) response to catecholamine(GO:0071869) response to epinephrine(GO:0071871) |
0.6 | 1.9 | GO:0019677 | pyridine nucleotide catabolic process(GO:0019364) NAD catabolic process(GO:0019677) pyridine-containing compound catabolic process(GO:0072526) |
0.6 | 3.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.6 | 3.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.6 | 1.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.6 | 4.8 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.6 | 2.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 13.6 | GO:0007568 | aging(GO:0007568) |
0.6 | 1.8 | GO:0046443 | FAD biosynthetic process(GO:0006747) FAD metabolic process(GO:0046443) flavin adenine dinucleotide metabolic process(GO:0072387) flavin adenine dinucleotide biosynthetic process(GO:0072388) |
0.6 | 2.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.6 | 15.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 1.7 | GO:0060031 | mediolateral intercalation(GO:0060031) |
0.6 | 8.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 5.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 2.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 2.3 | GO:0048618 | embryonic digestive tract morphogenesis(GO:0048557) post-embryonic foregut morphogenesis(GO:0048618) adenohypophysis morphogenesis(GO:0048855) |
0.6 | 1.7 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.6 | 3.9 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.6 | 8.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.5 | 1.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 12.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 4.3 | GO:0009791 | post-embryonic development(GO:0009791) |
0.5 | 1.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) negative regulation of cell maturation(GO:1903430) |
0.5 | 3.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 11.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.5 | 19.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 5.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 6.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.5 | 4.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.5 | 7.9 | GO:0072554 | endothelial tube morphogenesis(GO:0061154) blood vessel lumenization(GO:0072554) |
0.5 | 6.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 3.8 | GO:0040038 | meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
0.5 | 2.4 | GO:0097355 | protein localization to heterochromatin(GO:0097355) |
0.5 | 2.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 8.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.5 | 6.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.5 | 4.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 1.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 3.3 | GO:0090243 | fibroblast growth factor receptor signaling pathway involved in somitogenesis(GO:0090243) |
0.5 | 4.6 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.5 | 4.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.5 | 3.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 4.9 | GO:0006798 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
0.4 | 2.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.4 | 4.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.4 | 2.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) bone maturation(GO:0070977) |
0.4 | 3.5 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.4 | 4.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.4 | 10.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 1.7 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.4 | 11.7 | GO:0090148 | membrane fission(GO:0090148) |
0.4 | 3.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 2.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 11.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.7 | GO:1903292 | protein localization to Golgi membrane(GO:1903292) |
0.4 | 1.3 | GO:0035046 | pronuclear migration(GO:0035046) |
0.4 | 3.3 | GO:0046341 | CDP-diacylglycerol biosynthetic process(GO:0016024) CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.7 | GO:0071922 | regulation of sister chromatid cohesion(GO:0007063) regulation of cohesin loading(GO:0071922) |
0.4 | 3.3 | GO:0036372 | opsin transport(GO:0036372) |
0.4 | 4.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.4 | 10.1 | GO:0046466 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.4 | 2.0 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.4 | 13.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 3.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 3.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 3.2 | GO:0044211 | CTP salvage(GO:0044211) |
0.4 | 2.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 2.3 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.4 | 1.9 | GO:0050930 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) induction of positive chemotaxis(GO:0050930) |
0.4 | 1.5 | GO:0030576 | nuclear body organization(GO:0030575) Cajal body organization(GO:0030576) |
0.4 | 1.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.4 | 1.9 | GO:0060876 | semicircular canal formation(GO:0060876) |
0.4 | 8.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 2.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 2.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 11.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 4.8 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.4 | 5.5 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.4 | 1.1 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.4 | 3.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.4 | 18.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 2.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.4 | 2.2 | GO:0003232 | bulbus arteriosus development(GO:0003232) |
0.4 | 8.2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 1.1 | GO:0019348 | dolichol metabolic process(GO:0019348) dolichol biosynthetic process(GO:0019408) |
0.4 | 8.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 6.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 5.5 | GO:1902307 | positive regulation of sodium ion transport(GO:0010765) positive regulation of potassium ion transport(GO:0043268) positive regulation of potassium ion transmembrane transport(GO:1901381) positive regulation of sodium ion transmembrane transport(GO:1902307) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 7.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 2.4 | GO:0045619 | regulation of lymphocyte differentiation(GO:0045619) |
0.3 | 2.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.3 | 2.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 1.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 5.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 22.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 5.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 2.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.6 | GO:0032656 | interleukin-13 production(GO:0032616) regulation of interleukin-13 production(GO:0032656) |
0.3 | 3.6 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.3 | 1.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 88.2 | GO:0000377 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.3 | 2.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 4.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 15.5 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.3 | 8.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.3 | 1.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 1.9 | GO:0019427 | acetate metabolic process(GO:0006083) acetyl-CoA biosynthetic process from acetate(GO:0019427) |
0.3 | 6.7 | GO:0042098 | T cell proliferation(GO:0042098) regulation of T cell proliferation(GO:0042129) |
0.3 | 1.3 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.3 | 1.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 4.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 26.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.3 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.9 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 9.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 8.7 | GO:0048264 | determination of ventral identity(GO:0048264) |
0.3 | 2.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 6.3 | GO:0021551 | central nervous system morphogenesis(GO:0021551) |
0.3 | 9.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 6.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 4.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.3 | 13.4 | GO:0070830 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
0.3 | 2.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 25.1 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.3 | 11.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 2.8 | GO:0031268 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.5 | GO:1904825 | protein localization to microtubule(GO:0035372) protein localization to microtubule plus-end(GO:1904825) |
0.3 | 3.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.3 | 6.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 4.4 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.3 | 3.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 2.4 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.3 | 12.4 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
0.3 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 2.9 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.3 | 2.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 4.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 5.5 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.3 | 4.5 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.3 | 1.0 | GO:0061011 | gall bladder development(GO:0061010) hepatic duct development(GO:0061011) |
0.3 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.3 | 16.0 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 2.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 10.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 3.3 | GO:0014812 | muscle cell migration(GO:0014812) |
0.3 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 11.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 5.7 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.2 | 4.9 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.2 | 1.7 | GO:0046037 | GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
0.2 | 3.2 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 1.2 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 2.2 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 1.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 5.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 4.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 3.3 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.2 | 6.6 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 8.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 1.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 17.2 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.2 | 6.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 2.5 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 5.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 6.3 | GO:0035138 | pectoral fin morphogenesis(GO:0035138) |
0.2 | 0.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.3 | GO:0038065 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
0.2 | 8.7 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.2 | 2.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.5 | GO:2001106 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.2 | 3.0 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.2 | 5.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 5.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 1.7 | GO:0035188 | hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 3.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 4.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 4.0 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.2 | 12.3 | GO:0043065 | positive regulation of cell death(GO:0010942) positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
0.2 | 2.6 | GO:0043507 | activation of JUN kinase activity(GO:0007257) positive regulation of JUN kinase activity(GO:0043507) |
0.2 | 1.4 | GO:0010574 | vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) positive regulation of vascular endothelial growth factor production(GO:0010575) esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 3.3 | GO:0045010 | actin nucleation(GO:0045010) |
0.2 | 9.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 6.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.2 | 9.5 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.2 | 7.5 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.2 | 4.8 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.2 | 1.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 2.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 8.7 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.2 | 6.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.2 | 13.2 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.2 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0044878 | abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 0.7 | GO:0032534 | regulation of microvillus organization(GO:0032530) regulation of microvillus assembly(GO:0032534) |
0.2 | 1.2 | GO:0045050 | protein insertion into ER membrane by stop-transfer membrane-anchor sequence(GO:0045050) |
0.2 | 4.4 | GO:0009636 | response to toxic substance(GO:0009636) |
0.2 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 4.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.2 | 4.8 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) |
0.2 | 4.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 15.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.6 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 3.9 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.2 | 3.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.3 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 6.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 14.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 7.1 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.2 | 3.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 20.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 4.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 5.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 1.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 16.5 | GO:0008544 | epidermis development(GO:0008544) |
0.1 | 3.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:0070131 | regulation of mitochondrial translation(GO:0070129) positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.0 | GO:0009188 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 4.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 1.9 | GO:1905145 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.8 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.1 | 3.6 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.1 | 3.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 2.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 4.7 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 20.7 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 2.8 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) |
0.1 | 1.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 5.7 | GO:0030282 | bone mineralization(GO:0030282) |
0.1 | 2.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 4.2 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 1.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 2.8 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 3.4 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.1 | 8.0 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 1.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 1.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 12.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.7 | GO:0048714 | positive regulation of gliogenesis(GO:0014015) positive regulation of glial cell differentiation(GO:0045687) regulation of oligodendrocyte differentiation(GO:0048713) positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 3.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 1.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.4 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
0.1 | 1.6 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.1 | 1.9 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) response to interleukin-15(GO:0070672) cellular response to interleukin-15(GO:0071350) |
0.1 | 1.7 | GO:0098962 | regulation of postsynaptic neurotransmitter receptor activity(GO:0098962) |
0.1 | 4.6 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 2.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.1 | 3.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 3.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 22.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.5 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 6.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 1.7 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 6.9 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 3.8 | GO:0010469 | regulation of receptor activity(GO:0010469) |
0.1 | 4.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 4.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.1 | 1.1 | GO:0048016 | calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 1.7 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 1.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.4 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 1.0 | GO:0070085 | glycosylation(GO:0070085) |
0.1 | 2.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 2.2 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.1 | 0.5 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0051055 | negative regulation of lipid biosynthetic process(GO:0051055) |
0.1 | 10.6 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.8 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.1 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.7 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 3.7 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 1.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 5.1 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 1.5 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 1.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.0 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.8 | GO:0050708 | regulation of protein secretion(GO:0050708) |
0.0 | 1.0 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 1.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 7.0 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 2.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 1.7 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.5 | GO:0046683 | response to purine-containing compound(GO:0014074) response to ATP(GO:0033198) response to organophosphorus(GO:0046683) |
0.0 | 2.0 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.1 | GO:1904086 | regulation of epiboly involved in gastrulation with mouth forming second(GO:1904086) |
0.0 | 1.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 2.6 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 1.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 1.1 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 1.1 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 4.6 | GO:0072657 | protein localization to membrane(GO:0072657) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 2.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.2 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 1.3 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.0 | 2.0 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 0.0 | GO:0018393 | internal protein amino acid acetylation(GO:0006475) internal peptidyl-lysine acetylation(GO:0018393) peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 1.2 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0046102 | adenosine catabolic process(GO:0006154) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.0 | 0.2 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.1 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0060030 | dorsal convergence(GO:0060030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0034709 | methylosome(GO:0034709) |
2.4 | 19.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.0 | 28.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.8 | 9.1 | GO:0071439 | clathrin complex(GO:0071439) |
1.6 | 9.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.6 | 4.9 | GO:0031251 | PAN complex(GO:0031251) |
1.6 | 4.9 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.6 | 12.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.5 | 6.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.5 | 9.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.5 | 6.0 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
1.5 | 31.5 | GO:0005686 | U2 snRNP(GO:0005686) |
1.5 | 7.4 | GO:0071005 | U2-type precatalytic spliceosome(GO:0071005) |
1.4 | 13.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.3 | 23.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.3 | 7.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.2 | 10.8 | GO:0000974 | Prp19 complex(GO:0000974) |
1.2 | 13.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.2 | 4.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.2 | 4.6 | GO:0005688 | U6 snRNP(GO:0005688) |
1.2 | 8.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.0 | 6.0 | GO:0030891 | VCB complex(GO:0030891) |
1.0 | 4.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.9 | 2.8 | GO:0071012 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.9 | 2.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.9 | 4.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 10.1 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 5.5 | GO:0070695 | FHF complex(GO:0070695) |
0.9 | 4.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.9 | 14.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.9 | 12.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 4.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.8 | 7.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 14.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.8 | 4.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 3.6 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.7 | 5.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 4.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 12.5 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 7.5 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 14.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 12.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 3.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 4.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 3.6 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.6 | 3.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 2.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 4.0 | GO:0030892 | nuclear cohesin complex(GO:0000798) mitotic cohesin complex(GO:0030892) nuclear mitotic cohesin complex(GO:0034990) nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.6 | 2.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 5.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 4.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 3.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 4.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 7.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.5 | 22.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 7.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 29.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 5.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.5 | 16.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.5 | 65.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.5 | 5.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.5 | 34.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 17.1 | GO:0032156 | septin ring(GO:0005940) septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.4 | 9.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 1.3 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.4 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 7.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 3.4 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.4 | 47.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 3.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.4 | 7.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 5.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 7.6 | GO:0098844 | postsynaptic endocytic zone(GO:0098843) postsynaptic endocytic zone membrane(GO:0098844) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 0.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 2.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 5.8 | GO:0070187 | telosome(GO:0070187) |
0.4 | 3.0 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 52.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 4.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 2.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 2.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 26.5 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 1.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 4.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 2.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 3.4 | GO:0005903 | brush border(GO:0005903) |
0.3 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 7.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 2.2 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.3 | 4.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 8.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 8.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 94.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.4 | GO:0070390 | transcription export complex 2(GO:0070390) |
0.3 | 12.1 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 5.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 3.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 2.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 3.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 7.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 11.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 4.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 7.9 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 13.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 4.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.2 | 4.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.7 | GO:0016586 | RSC complex(GO:0016586) |
0.2 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 17.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 3.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 1.5 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 1.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 16.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 13.1 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.2 | 6.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.0 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.2 | 3.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 3.7 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 7.3 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 2.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.8 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.3 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 1.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 13.6 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 34.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 10.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 5.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 2.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 6.0 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 2.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.7 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 4.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 34.4 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 7.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) |
0.1 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.8 | GO:0044545 | NSL complex(GO:0044545) |
0.1 | 13.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) |
0.1 | 0.7 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 2.2 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 6.2 | GO:0005764 | lysosome(GO:0005764) |
0.0 | 2.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.7 | GO:0098978 | glutamatergic synapse(GO:0098978) |
0.0 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 2.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 9.6 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 2.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 13.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 2.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 22.1 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
3.2 | 12.6 | GO:0003796 | lysozyme activity(GO:0003796) |
3.2 | 9.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
3.0 | 8.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.8 | 30.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.8 | 19.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
2.6 | 7.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.3 | 9.4 | GO:0008117 | sphinganine-1-phosphate aldolase activity(GO:0008117) |
2.2 | 6.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.0 | 7.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
2.0 | 7.9 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
1.9 | 5.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.8 | 5.3 | GO:0003978 | UDP-glucose 4-epimerase activity(GO:0003978) |
1.7 | 12.1 | GO:0019809 | spermidine binding(GO:0019809) |
1.6 | 4.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) IgE receptor activity(GO:0019767) |
1.6 | 12.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.6 | 4.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.6 | 6.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.5 | 7.7 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
1.5 | 7.4 | GO:0016531 | copper chaperone activity(GO:0016531) |
1.5 | 5.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.5 | 5.9 | GO:0102345 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.5 | 17.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 8.4 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
1.3 | 4.0 | GO:0001734 | mRNA (N6-adenosine)-methyltransferase activity(GO:0001734) |
1.3 | 3.9 | GO:0051765 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) |
1.2 | 3.7 | GO:0045545 | syndecan binding(GO:0045545) |
1.2 | 4.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.2 | 3.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 3.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.2 | 8.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.2 | 20.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.1 | 4.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 4.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.1 | 7.9 | GO:0035173 | histone kinase activity(GO:0035173) |
1.1 | 5.4 | GO:1990756 | protein binding, bridging involved in substrate recognition for ubiquitination(GO:1990756) |
1.0 | 6.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.0 | 7.1 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.0 | 3.0 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) calcitonin gene-related peptide receptor activity(GO:0001635) |
1.0 | 7.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.0 | 19.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 8.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.0 | 2.9 | GO:0031704 | apelin receptor binding(GO:0031704) |
1.0 | 3.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.9 | 2.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.9 | 9.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.9 | 7.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 8.8 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.9 | 6.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.9 | 14.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.9 | 4.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.9 | 8.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.9 | 2.6 | GO:0030623 | U5 snRNA binding(GO:0030623) |
0.8 | 8.4 | GO:0015924 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.8 | 4.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 3.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 6.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 17.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 4.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.8 | 2.4 | GO:0047453 | ATP-dependent NAD(P)H-hydrate dehydratase activity(GO:0047453) ADP-dependent NAD(P)H-hydrate dehydratase activity(GO:0052855) |
0.8 | 7.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 6.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.8 | 8.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 11.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 2.9 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.7 | 10.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.7 | 14.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 4.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 7.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 2.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.7 | 2.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.7 | 9.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 2.6 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.6 | 9.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.6 | 1.9 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.6 | 1.9 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
0.6 | 10.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 1.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 10.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 4.9 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.6 | 1.8 | GO:0003919 | FMN adenylyltransferase activity(GO:0003919) |
0.6 | 3.0 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.6 | 2.9 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.6 | 2.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.6 | 3.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 4.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 4.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.6 | 3.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 5.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 6.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 4.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 41.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 2.0 | GO:0022889 | serine transmembrane transporter activity(GO:0022889) |
0.5 | 23.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 3.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 1.5 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 6.4 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.5 | 2.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 17.7 | GO:0099604 | ligand-gated calcium channel activity(GO:0099604) |
0.5 | 7.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) |
0.5 | 19.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 1.9 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.5 | 3.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 4.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 3.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 1.4 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
0.5 | 5.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 1.8 | GO:0047611 | acetylspermidine deacetylase activity(GO:0047611) |
0.4 | 4.9 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
0.4 | 3.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 2.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 1.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 4.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 7.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) uridine-diphosphatase activity(GO:0045134) |
0.4 | 11.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 4.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 3.2 | GO:0019206 | uridine kinase activity(GO:0004849) nucleoside kinase activity(GO:0019206) |
0.4 | 2.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 3.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.9 | GO:0050218 | propionate-CoA ligase activity(GO:0050218) |
0.4 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 3.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 5.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 12.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 3.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 2.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 3.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.4 | 2.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 3.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 8.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 18.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 4.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 9.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 5.6 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.0 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.3 | 5.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) potassium channel inhibitor activity(GO:0019870) |
0.3 | 9.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 2.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 1.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) |
0.3 | 3.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 6.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 7.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 7.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 4.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 9.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 4.1 | GO:0043028 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 7.2 | GO:0031267 | small GTPase binding(GO:0031267) |
0.3 | 4.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.3 | 12.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 1.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.3 | 4.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 7.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 9.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 1.4 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 6.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 19.3 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.3 | 2.0 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.3 | 10.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 10.3 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 6.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 1.9 | GO:0008118 | N-acetyllactosaminide alpha-2,3-sialyltransferase activity(GO:0008118) |
0.3 | 5.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 2.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.1 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 3.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 3.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 2.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 2.2 | GO:0038064 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
0.2 | 5.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 3.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 28.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.9 | GO:0072518 | Rho-dependent protein serine/threonine kinase activity(GO:0072518) |
0.2 | 3.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 2.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 4.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 4.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 2.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 3.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 7.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 19.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.9 | GO:0008488 | gamma-glutamyl carboxylase activity(GO:0008488) |
0.2 | 18.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 11.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 3.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 3.9 | GO:0019211 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.2 | 2.5 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.2 | 1.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 2.2 | GO:0030172 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.2 | 3.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 5.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 43.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 2.0 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 3.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 5.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 2.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 5.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 61.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 2.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 6.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 6.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.6 | GO:0033204 | ribonuclease P RNA binding(GO:0033204) |
0.2 | 1.7 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.2 | 2.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 3.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 2.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 5.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.1 | 3.6 | GO:0004698 | protein kinase C activity(GO:0004697) calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 7.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 17.3 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 6.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 6.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 3.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 9.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 11.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 10.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0001016 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 3 promoter sequence-specific DNA binding(GO:0001006) RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 6.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 2.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 3.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 60.5 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.8 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.4 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.3 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 7.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 7.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 1.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 5.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 10.3 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 4.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 2.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 1.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 5.2 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 1.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 3.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 19.5 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 4.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 24.0 | GO:0003712 | transcription factor activity, transcription factor binding(GO:0000989) transcription cofactor activity(GO:0003712) |
0.1 | 3.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.7 | GO:0031682 | G-protein gamma-subunit binding(GO:0031682) |
0.1 | 2.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 3.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 17.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 9.6 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 3.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 1.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 2.3 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 6.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 2.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 26.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 2.5 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.0 | 1.5 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 2.9 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.8 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0036374 | peptidyltransferase activity(GO:0000048) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0001948 | glycoprotein binding(GO:0001948) proteoglycan binding(GO:0043394) |
0.0 | 8.9 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 15.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.0 | 13.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 5.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.9 | 13.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.9 | 45.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 28.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 4.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 19.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 15.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 12.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 9.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 7.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 16.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 4.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 6.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 3.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 4.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 12.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 11.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 7.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 18.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 2.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 4.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 3.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 2.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 5.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 9.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 2.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 11.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 10.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 10.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 2.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 6.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 3.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 3.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 4.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 5.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 4.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.3 | 14.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.3 | 7.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
1.2 | 19.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.2 | 9.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.1 | 18.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 2.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.1 | 12.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.0 | 14.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 11.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.0 | 8.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 11.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 5.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.8 | 13.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.8 | 10.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 21.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.7 | 6.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.7 | 23.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.7 | 6.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 1.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 3.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.7 | 4.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 4.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 4.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 8.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 7.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 6.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 11.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 9.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 8.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 11.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 11.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.5 | 10.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 1.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 18.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 4.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 4.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 5.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.4 | 3.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 1.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 4.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 6.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 4.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 6.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 11.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 5.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 4.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 4.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 6.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 7.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 2.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 17.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 23.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 7.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 3.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 5.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 29.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 5.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 5.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 7.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 12.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 1.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.7 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 6.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 5.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 5.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 3.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 7.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 5.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 4.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 8.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 3.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 4.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 2.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |